Polymyxin B (Alvogen Inc.)


Welcome to the PulseAid listing for the Polymyxin B drug offered from Alvogen Inc.. This Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Alvogen Inc.
NON-PROPRIETARY NAME: polymyxin B sulfate
SUBSTANCE NAME: POLYMYXIN B SULFATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-09-23
END MARKETING DATE: 0000-00-00


Polymyxin B HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPolymyxin B from Alvogen Inc.
LABELER NAME: Alvogen Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500000([iU]/1)
START MARKETING DATE: 2017-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47781-596_89406b65-8778-f74e-c3d8-cbad6606dfde
PRODUCT NDC: 47781-596
APPLICATION NUMBER: ANDA207322

Other POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Polymyxin B
Athenex Pharmaceutical Division, LLC.Polymyxin B
AuroMedics Pharma LLCPolymyxin B
Breckenridge Pharmaceutical, Inc.Polymyxin B
Fresenius Kabi USA, LLCPolymyxin B
Gland Pharma LimitedPOLYMYXIN B
X-GEN Pharmaceuticals, Inc.Polymyxin B
Xellia Pharmaceuticals ApSPOLYMYXIN B